AOD9604

AOD-9604 – Research Peptide

Human Growth Hormone Fragment for Lipid Metabolism, Adipose Tissue & Metabolic Research

AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone (hGH). It was developed as an experimental analogue of the hGH 176–191 fragment, with particular scientific interest in lipid metabolism, adipose tissue biology, lipolysis, lipogenesis and metabolic regulation.

AOD-9604 was originally investigated as a potential approach to modifying fat metabolism without reproducing the full spectrum of biological effects associated with intact human growth hormone.

Its research history includes preclinical studies examining lipid-related metabolic pathways and human clinical investigations into weight management.

Although early experimental findings generated interest in AOD-9604, subsequent clinical development did not establish a meaningful weight-loss benefit in humans.

Today, AOD-9604 remains relevant to research involving growth hormone fragment biology, adipocyte metabolism, lipid regulation and experimental metabolic pharmacology.

ICAME Pharmacy AOD-9604 is intended strictly for laboratory research and development purposes. It is not intended for human or veterinary use.

What Is AOD-9604?

AOD-9604 is a modified peptide based on amino acids 176–191 of human growth hormone.

Human growth hormone is a peptide hormone involved in numerous physiological processes, including growth, metabolic regulation and body composition.

The full growth hormone molecule interacts with the growth hormone receptor and influences multiple downstream signaling pathways.

AOD-9604 was developed to investigate whether a shorter region of the growth hormone molecule could reproduce selected lipid-related effects without the broader growth-promoting activity of the complete hormone.

Its name is commonly associated with the research designation Anti-Obesity Drug 9604.

AOD-9604 has been investigated in connection with:

• Lipid metabolism

• Adipose tissue biology

• Lipolysis

• Lipogenesis

• Fatty-acid metabolism

• Growth hormone fragment research

• Metabolic homeostasis

• Experimental obesity research

• Adipocyte signaling

AOD-9604 should not be confused with full-length human growth hormone or assumed to have identical biological activity.

AOD-9604 and Human Growth Hormone Research

Human growth hormone consists of 191 amino acids and participates in a wide range of physiological functions.

Researchers have investigated whether specific regions of the hormone contribute to distinct biological activities.

The C-terminal region, including amino acids 176–191, attracted attention because early experimental work suggested that fragments derived from this region could influence lipid metabolism.

AOD-9604 was designed as a modified analogue of this region.

The scientific objective was to investigate lipid-related metabolic activity while reducing the broader endocrine effects associated with intact growth hormone.

However, the biological properties of a peptide fragment cannot be assumed to match those of the complete parent hormone.

The activity of AOD-9604 must therefore be evaluated independently.

Proposed Mechanism of Action

AOD-9604 was investigated primarily for its potential effects on lipid metabolism.

Early preclinical research examined two major processes:

Lipolysis: The breakdown of stored triglycerides into fatty acids and glycerol.

Lipogenesis: The synthesis and storage of fatty acids and triglycerides.

The proposed metabolic effects of AOD-9604 have been investigated in experimental adipose tissue and animal models.

Simplified Research Pathway

AOD-9604

↓

Adipose Tissue & Metabolic Signaling

↓

Experimental Investigation of Lipid Metabolism

↓

Lipolysis / Lipogenesis Pathways

↓

Adipocyte Metabolic Responses

The precise molecular targets responsible for the reported experimental effects remain incompletely established.

AOD-9604 should therefore not be described as a proven selective activator of fat breakdown or inhibitor of fat storage in humans.

AOD-9604 and Lipolysis Research

Lipolysis is the biochemical process through which stored triglycerides are broken down into free fatty acids and glycerol.

This process is essential for mobilizing stored energy.

Lipolysis is regulated by multiple hormonal and cellular signaling pathways, including those involving catecholamines, insulin and intracellular metabolic enzymes.

Early research involving growth hormone fragments investigated whether selected peptide regions could influence lipolytic activity.

AOD-9604 was subsequently studied as a modified peptide designed to explore these lipid-related mechanisms.

Experimental findings in animal and laboratory models generated interest in its possible effects on fat metabolism.

However, these observations do not establish that AOD-9604 produces clinically meaningful fat loss in humans.

AOD-9604 and Lipogenesis Research

Lipogenesis refers to the synthesis of fatty acids and their incorporation into storage lipids.

It is an important component of cellular and systemic energy balance.

Adipose tissue regulates lipid storage according to nutrient availability, hormonal signals and metabolic demand.

AOD-9604 has been investigated in experimental research involving pathways associated with lipid storage and metabolic regulation.

Potential research questions include:

• How adipocytes regulate lipid accumulation

• How lipid synthesis responds to metabolic signals

• How growth hormone fragments interact with fat metabolism

• How lipid storage and mobilization are coordinated

• Whether peptide fragments influence adipose tissue metabolic activity

These remain research questions rather than established therapeutic effects.

AOD-9604 and Adipose Tissue Biology

Adipose tissue is a metabolically active organ involved in energy storage, endocrine signaling and systemic metabolic regulation.

Adipocytes participate in processes including:

Triglyceride storage

Fatty-acid release

Energy homeostasis

Adipokine signaling

Insulin-related metabolic responses

Metabolic adaptation

AOD-9604 has been investigated in relation to selected aspects of adipose tissue metabolism.

Its development history makes it particularly relevant to research examining the biological effects of growth hormone-derived fragments on fat-cell metabolism.

AOD-9604 and Fatty-Acid Metabolism

Fatty acids are essential components of cellular membranes and important substrates for energy metabolism.

Their metabolism involves several interconnected processes:

Fatty-acid synthesis

Triglyceride storage

Lipolysis

Fatty-acid transport

Beta-oxidation

Energy production

AOD-9604 research has focused primarily on lipid mobilization and storage rather than demonstrating a direct, clinically established effect on every stage of fatty-acid metabolism.

For this reason, research into AOD-9604 should distinguish between observed experimental changes in lipid pathways and broader assumptions about systemic energy expenditure.

AOD-9604 and Metabolic Research

Metabolic homeostasis requires coordination between nutrient intake, energy storage and energy utilization.

Adipose tissue plays a central role in this balance.

AOD-9604 has been investigated as an experimental compound within the broader field of metabolic regulation.

Research areas include:

• Adipocyte metabolism

• Lipid storage

• Lipid mobilization

• Fatty-acid regulation

• Growth hormone fragment activity

• Metabolic signaling

• Experimental obesity biology

The scientific value of AOD-9604 lies partly in its development as a molecule intended to separate selected metabolic effects of growth hormone from the activity of the full hormone.

AOD-9604 and Growth Hormone Receptor Signaling

Full-length human growth hormone binds to the growth hormone receptor and activates downstream signaling pathways, including JAK2/STAT-associated mechanisms.

These pathways contribute to growth, metabolic regulation and other physiological responses.

AOD-9604 is structurally distinct from intact growth hormone.

It was investigated with the objective of influencing selected metabolic pathways without reproducing the full growth-promoting activity of the parent hormone.

However, the absence of particular growth hormone-like effects in experimental systems should not be interpreted as proof that AOD-9604 is free from systemic risks.

The receptor interactions and complete pharmacological profile of AOD-9604 remain less comprehensively characterized than those of approved growth hormone medicines.

AOD-9604 and Experimental Obesity Research

AOD-9604 was developed partly in response to scientific interest in the relationship between growth hormone biology and fat metabolism.

Preclinical studies investigated whether the peptide could influence body-fat-related metabolic processes.

These early observations led to clinical development programs evaluating AOD-9604 as a potential weight-management compound.

However, promising results in laboratory and animal models do not necessarily translate into clinically meaningful outcomes in humans.

This distinction became especially important during the subsequent human development program.

Human Clinical Research on AOD-9604

AOD-9604 has been evaluated in human clinical studies, including investigations into its potential effects on body weight.

Early clinical research explored the compound's pharmacological properties and its possible role in weight management.

However, a larger clinical development program failed to demonstrate the anticipated weight-loss efficacy.

As a result, development of AOD-9604 as an anti-obesity medicine was discontinued.

This history is important when interpreting claims about AOD-9604.

AOD-9604 has not been established as an effective human weight-loss treatment.

Evidence from preclinical lipolysis research should not be presented as proof of clinically significant fat reduction.

AOD-9604 and Cartilage Research

AOD-9604 has also appeared in experimental research examining cartilage and musculoskeletal biology.

Some preclinical investigations have explored potential effects of growth hormone-derived peptides in models involving cartilage tissue and joint-associated biological processes.

These studies represent a separate research area from AOD-9604's original metabolic development program.

Potential areas of scientific investigation include:

• Chondrocyte biology

• Cartilage matrix regulation

• Musculoskeletal tissue responses

• Experimental tissue repair mechanisms

The available evidence does not establish AOD-9604 as an approved or clinically effective treatment for cartilage damage, osteoarthritis or joint disorders.

AOD-9604 and Cellular Metabolic Signaling

Lipid metabolism depends on interactions between hormones, enzymes and intracellular signaling networks.

Researchers investigating AOD-9604 may examine relationships involving:

Adipocyte signaling

Lipid storage pathways

Fatty-acid mobilization

Hormonal metabolic regulation

Cellular energy balance

Growth hormone fragment activity

Because AOD-9604's precise molecular mechanism remains incompletely characterized, experimental results should be interpreted with appropriate mechanistic controls.

Potential Research Applications

AOD-9604 may be of interest in controlled scientific investigations involving:

• Human growth hormone fragment biology

• Lipid metabolism

• Lipolysis research

• Lipogenesis research

• Adipose tissue biology

• Adipocyte signaling

• Fatty-acid metabolism

• Metabolic homeostasis

• Experimental obesity biology

• Hormonal metabolic signaling

• Growth hormone-associated metabolic pathways

• Cartilage biology

• Musculoskeletal research

• Experimental pharmacology

• Peptide structure–activity relationships

AOD-9604 remains a compound of scientific interest for investigating the relationship between peptide structure and selected metabolic responses.

AOD-9604 vs. Human Growth Hormone

Although AOD-9604 is derived from a region of human growth hormone, the two molecules are not interchangeable.

The distinction is important for accurate scientific interpretation and responsible product positioning.

Current State of Research

AOD-9604 has a research history spanning preclinical investigations and human clinical development.

The overall evidence can be summarized as follows:

Preclinical research: Investigated lipid metabolism and growth hormone fragment biology.

Human clinical research: Evaluated AOD-9604 as a potential weight-management compound.

Clinical outcome: Did not establish the expected weight-loss efficacy.

Other research areas: Limited experimental investigations involving cartilage and musculoskeletal biology.

Current status: A research compound without an established approved therapeutic indication.

AOD-9604 should therefore be described as an investigational peptide with a history of metabolic research, not as a proven fat-loss or anti-obesity treatment.

AOD-9604 Research Overview

Compound: AOD-9604

Alternative Description: Modified Human Growth Hormone Fragment 176–191

Peptide Classification: Synthetic Growth Hormone-Derived Peptide

Parent Molecule: Human Growth Hormone (hGH)

Primary Historical Research Area: Lipid Metabolism

Additional Research Areas: Adipose Tissue Biology / Metabolic Signaling / Experimental Cartilage Research

Clinical Status: No established approved therapeutic indication

Product Information

Product Name: AOD-9604

Brand: ICAME Pharmacy

Product Category: Research Peptide

Research Classification: Synthetic Human Growth Hormone Fragment Analogue

Research Area: Lipid Metabolism / Adipose Tissue Biology / Metabolic Research

Intended Use: Laboratory Research & Development Only

The exact peptide sequence, chemical form and molecular specifications of the supplied AOD-9604 should be confirmed using the manufacturer's product documentation.

Batch-specific information, including purity, analytical methodology, Certificate of Analysis (COA), batch/lot identification and validated storage conditions, should be provided according to documentation associated with each individual production batch.

Important Research Use Notice

FOR RESEARCH USE ONLY (RUO)

This ICAME Pharmacy product is intended exclusively for legitimate laboratory, analytical and scientific research purposes.

Not for human or veterinary use. Not for diagnostic, therapeutic, weight-management, fat-loss, muscle-development or performance-enhancing purposes. Not for direct administration to humans or animals.

AOD-9604 is not an approved anti-obesity medicine, and its clinical development history does not establish effective weight reduction in humans.

Experimental findings involving lipid metabolism should not be interpreted as evidence of established human efficacy or safety.

Information presented on this page is intended solely for scientific and educational purposes and should not be interpreted as medical advice, prescribing information, dosage guidance or instructions for human use.

About ICAME Pharmacy

ICAME Pharmacy provides specialized research products for professional laboratory and scientific applications.

Our portfolio focuses on compounds relevant to contemporary areas of peptide science, molecular biology, cellular metabolism, lipid research, mitochondrial science and experimental life sciences.

Product information is presented with an emphasis on responsible research use, scientific transparency, clear product identification and professional research applications.

For batch-specific documentation, analytical information and product inquiries, please contact ICAME Pharmacy.